Icon
+91 94997 68112
Login Register

QUIXIN (nda021199)- (0.5%)

LEVOFLOXACIN SANTEN
0.5%
Yes No
2010-Dec-20 Expired
None None
None No
QUIXIN ® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: *Gram-positive bacteria: Corynebacterium species, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumonia, Streptococcus (Groups C/F), Streptococcus (Group G), Viridans group streptococci. *Gram-negative bacteria: Acinetobacter lwoffii, Haemophilus influenzae, Serratia marcescens.
2 0 2
Total Other Developers None
Drugs with Suitability No
0.5% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****,, ***, *** ******, ***** (***) ***
****** ******** ****** ***** ********* ******* *** (*** *****) *********** ** ******** *** *** *, ********, *** ****** (**) *****-****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.